DexCom Inc DXCM Delivers Strong Q1 2026 Performance with Accelerating Revenue Growth and Margin Expansion HITI High Tide shares gain 167 percent after posting negative Q4 2025 earnings per share BDRX Biodexa highlights rare disease therapy pipeline progress as it releases its latest quarterly earnings report AVNS Avanos posts Q4 2025 earnings per share 146 percent above estimates ticks higher in daily trading EQPT Q1 2026 Earnings NarrowerThanExpected Loss Beats Consensus Estimates Musk and US Government Challenge Colorado AI AntiDiscrimination Law Janux Therapeutics JANX Rallies 377 as Bulls Target 1505 20260520 Lincoln International Valued at 23 Billion as Shares Jump in NYSE Debut